Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Occupational and Environmental Medicine · Bronchiolitis Obliterans

Subtypes and Causes: Why Did This Happen?

At a Glance

Non-transplant bronchiolitis obliterans can follow toxic inhalation, severe respiratory infection, autoimmune disease, or certain medicines; some cases have no known cause. Finding the likely trigger helps guide exposure avoidance, specialist evaluation, and monitoring.

Understanding why you developed bronchiolitis obliterans is a key step in managing the condition. Because this disease is rare outside of lung transplants, doctors look for specific triggers that may have caused the initial injury to your small airways. Scientists generally group these causes into common cause categories [1][2]. Identifying your category helps your care team predict how the disease might behave and what steps you can take to protect your remaining lung function. Keep in mind that some patients have overlapping triggers, and many cases remain cryptogenic (having no identifiable cause).

1. Occupational and Inhalational Exposures

This category occurs when you breathe in toxic substances that irritate and scar the tiny bronchioles.

  • Flavoring Chemicals: One of the most well-known causes is diacetyl (and its relative, 2,3-pentanedione), chemicals used to give foods a buttery flavor [3][4]. This was famously linked to “Popcorn Lung” in workers at microwave popcorn plants, but it is also found in coffee processing and other food production [3][5].
  • Toxic Gases and Dusts: Inhalation of nitrogen dioxide (found in farm silos), sulfur mustard, or certain metal dusts can cause acute injury that leads to permanent scarring [6][2].
  • Military Burn Pits: Veterans may have been exposed to complex mixtures of desert dust and smoke from burn pits. While research is ongoing and findings vary by study, some personnel have been diagnosed with constrictive bronchiolitis following these exposures [7].

Disease Behavior: In these cases, the disease often evolves slowly after years of exposure. The most critical intervention is complete removal from the exposure source to prevent further damage [8][6]. You should ask your doctor for a referral to an occupational/environmental medicine specialist to safely document exposures and guide workplace accommodations.

2. Post-Infectious (PIBO)

Post-infectious bronchiolitis obliterans (PIBO) occurs after a severe respiratory infection that permanently scars the airways during the healing process [9].

  • Childhood Origins: Most cases are diagnosed in infants or young children who survive a life-threatening bout of adenovirus or Mycoplasma pneumoniae [9][10].
  • Risk Factors: Children who required a ventilator (breathing machine) or heavy oxygen support during their infection are at much higher risk for developing PIBO [11][12].
  • Adults: While less common in adults, severe viral or bacterial infections can occasionally lead to similar airway scarring [13][14].

Disease Behavior: While PIBO causes significant lung impairment, many children find their condition appears to stabilize or improve as they grow. This apparent improvement is often because their lungs physically enlarge as they grow, not because the established scar tissue reverses [15][16].

3. Autoimmune and Connective Tissue Diseases

Sometimes, the body’s own immune system attacks the small airways as part of a systemic (body-wide) condition. This is most common in:

  • Rheumatoid Arthritis (RA): This is the most frequent autoimmune cause. It often affects women in their 50s and can present as a “fixed” narrowing of the airways that doesn’t respond well to standard asthma inhalers [17][18].
  • Sjögren’s Syndrome: A condition characterized by dry eyes and mouth that can also cause inflammation in the lung’s small airways [18][19].

Disease Behavior: In RA-related cases, the lung function often remains stable for long periods, although symptoms like shortness of breath may persist [17]. Treatment focuses on managing the underlying autoimmune disease, sometimes using specialist-directed immunosuppressants [19][17]. Note that negative blood tests for rheumatoid factor or anti-CCP do not completely rule out an autoimmune cause, and positive tests do not prove the airway disease is caused by it. Diagnosis often requires a rheumatologist.

4. Drug-Induced Bronchiolitis Obliterans

Certain medications can trigger airway scarring as a rare side effect [2].

  • Traditional Medications: Drugs like penicillamine (used for RA or Wilson’s disease) and gold salts were historically linked to this condition [2].
  • Modern Therapies: Newer cancer treatments known as immune-checkpoint inhibitors (such as pembrolizumab or nivolumab) have had rare reported immune-related cases of bronchiolitis obliterans [20].

Disease Behavior: If a medication is the cause, stopping the drug is the first step. You must not stop a prescribed medication on your own. You must contact your prescriber urgently, especially an oncologist, because substitution or tapering may be needed and stopping a life-saving drug abruptly carries severe risks. Because the scarring is physical (fibrosis), stopping the medication does not always reverse the damage already done to the lungs [20].

Common questions in this guide

What can cause non-transplant bronchiolitis obliterans?
Possible causes include breathing in toxic chemicals or dust, a severe respiratory infection, an autoimmune disease such as rheumatoid arthritis or Sjögren’s syndrome, and certain medicines. Some people have no identifiable cause, and more than one trigger may be involved.
Can workplace exposure to diacetyl cause popcorn lung?
Diacetyl and a related chemical called 2,3-pentanedione can injure and scar the small airways, which is why this condition has been called popcorn lung. These chemicals may be encountered in microwave-popcorn production, coffee processing, and other food manufacturing, so complete removal from the exposure is important.
Can a childhood infection lead to bronchiolitis obliterans later?
Yes. Post-infectious bronchiolitis obliterans can develop after a severe childhood infection, particularly adenovirus or Mycoplasma pneumoniae, and the risk is higher when a child needed a ventilator or substantial oxygen support. Lung function may seem to improve as the child grows, but established scar tissue does not necessarily disappear.
Which autoimmune diseases are linked to bronchiolitis obliterans?
Rheumatoid arthritis is the most frequently reported autoimmune association, and Sjögren’s syndrome can also affect the small airways. Blood tests such as rheumatoid factor or anti-CCP can provide information, but a positive result does not prove the cause and a negative result does not completely exclude it.
Can a medication cause bronchiolitis obliterans, and should I stop taking it?
Rare cases have been linked to medicines such as penicillamine, gold salts, and immune-checkpoint inhibitors. Do not stop a prescribed medication on your own; contact the prescriber urgently because you may need a substitute or supervised taper, and stopping the drug may not reverse existing lung scarring.
Could military burn-pit exposure be related to this condition?
Some military personnel exposed to mixtures of burn-pit smoke and desert dust have been diagnosed with constrictive bronchiolitis, although research findings vary. An occupational or environmental medicine specialist can help document the exposure and discuss workplace or service-related support.

Get notified when new evidence is published on Non-transplant-related bronchiolitis obliterans.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    Obliterative Bronchiolitis.

    Aguilar PR, Michelson AP, Isakow W

    Transplantation 2016; (100(2)):272-83 doi:10.1097/TP.0000000000000892.

    PMID: 26335918
  2. 2

    Bronchiolitis and Bronchiolar Disorders.

    Ravaglia C, Poletti V

    Seminars in respiratory and critical care medicine 2020; (41(2)):311-332 doi:10.1055/s-0039-3402728.

    PMID: 32279301
  3. 3

    Update on flavoring-induced lung disease.

    Holden VK, Hines SE

    Current opinion in pulmonary medicine 2016; (22(2)):158-64 doi:10.1097/MCP.0000000000000250.

    PMID: 26761629
  4. 4

    Flavorings-Related Lung Disease: A Brief Review and New Mechanistic Data.

    Hubbs AF, Kreiss K, Cummings KJ, et al.

    Toxicologic pathology 2019; (47(8)):1012-1026 doi:10.1177/0192623319879906.

    PMID: 31645208
  5. 5

    Case Report: Flavoring-Related Lung Disease in a Coffee Roasting and Packaging Facility Worker With Unique Lung Histopathology Compared With Previously Described Cases of Obliterative Bronchiolitis.

    Harvey RR, Blackley BH, Korbach EJ, et al.

    Frontiers in public health 2021; (9()):657987 doi:10.3389/fpubh.2021.657987.

    PMID: 34095061
  6. 6

    Inhalational Constrictive Bronchiolitis: The Evolution of our Understanding of this Disease.

    Banks DE, Morris MJ

    Lung 2021; (199(4)):327-334 doi:10.1007/s00408-021-00466-2.

    PMID: 34415399
  7. 7

    Respiratory Health after Military Service in Southwest Asia and Afghanistan. An Official American Thoracic Society Workshop Report.

    Garshick E, Abraham JH, Baird CP, et al.

    Annals of the American Thoracic Society 2019; (16(8)):e1-e16 doi:10.1513/AnnalsATS.201904-344WS.

    PMID: 31368802
  8. 8

    Early detection, clinical diagnosis, and management of lung disease from exposure to diacetyl.

    Rose CS

    Toxicology 2017; (388()):9-14 doi:10.1016/j.tox.2017.03.019.

    PMID: 28344095
  9. 9

    Younger Age and Viral Triggers Were Associated With Post-Infectious Bronchiolitis Obliterans in French Children.

    Mazenq J, Crebassa M, Hadchouel A, et al.

    Acta paediatrica (Oslo, Norway : 1992) 2025; (114(11)):2900-2908 doi:10.1111/apa.70188.

    PMID: 40548825
  10. 10

    Risk factors for bronchiolitis obliterans development in children after Mycoplasma pneumoniae pneumonia: a retrospective study of 981 patients.

    Xu W, Wang H, Wen X, et al.

    Italian journal of pediatrics 2025; (51(1)):105 doi:10.1186/s13052-025-01932-w.

    PMID: 40165275
  11. 11

    Risk Factors for Post-infectious Bronchiolitis Obliterans in Children: A Systematic Review and Meta-Analysis.

    Liu D, Liu J, Zhang L, et al.

    Frontiers in pediatrics 2022; (10()):881908 doi:10.3389/fped.2022.881908.

    PMID: 35757133
  12. 12

    Risk factors for bronchiolitis obliterans complicating adenovirus pneumonia in children: a meta-analysis.

    Yao MM, Gao TJ, Zhao M, et al.

    Frontiers in pediatrics 2024; (12()):1361850 doi:10.3389/fped.2024.1361850.

    PMID: 39149537
  13. 13

    Etiology and Outcome of Diffuse Acute Infectious Bronchiolitis in Adults.

    Ryu K, Takayanagi N, Ishiguro T, et al.

    Annals of the American Thoracic Society 2015; (12(12)):1781-7 doi:10.1513/AnnalsATS.201507-473OC.

    PMID: 26524622
  14. 14

    Postinfectious Bronchiolitis Obliterans Misdiagnosed as Bronchial Asthma in a Pediatric Patient.

    Fujita Y, Miyamoto K, Imataka G, Yoshihara S

    The Tohoku journal of experimental medicine 2021; (254(4)):257-260 doi:10.1620/tjem.254.257.

    PMID: 34408104
  15. 15

    Pulmonary Function in Post-Infectious Bronchiolitis Obliterans in Children: A Systematic Review and Meta-Analysis.

    Lee E, Park S, Yang HJ

    Pathogens (Basel, Switzerland) 2022; (11(12)) doi:10.3390/pathogens11121538.

    PMID: 36558872
  16. 16

    Childhood bronchiolitis obliterans in Hong Kong-case series over a 20-year period.

    Chan KC, Yu MW, Cheung TWY, et al.

    Pediatric pulmonology 2021; (56(1)):153-161 doi:10.1002/ppul.25166.

    PMID: 33174693
  17. 17

    Obliterative bronchiolitis associated with rheumatoid arthritis: analysis of a single-center case series.

    Lin E, Limper AH, Moua T

    BMC pulmonary medicine 2018; (18(1)):105 doi:10.1186/s12890-018-0673-x.

    PMID: 29929518
  18. 18

    Bronchiolar disorders in systemic autoimmune rheumatic diseases.

    Kluanwan Y, Tangnuntachai N, Ryu JH, Moua T

    European respiratory review : an official journal of the European Respiratory Society 2025; (34(176)) doi:10.1183/16000617.0248-2024.

    PMID: 40240060
  19. 19

    Improvement of constrictive bronchiolitis (bronchiolitis obliterans) after rituximab therapy in 2 patients with primary sjögren syndrome.

    Lipatov K, Kubbara AF, Weerheim LE, et al.

    Respiratory medicine case reports 2021; (33()):101432 doi:10.1016/j.rmcr.2021.101432.

    PMID: 34401276
  20. 20

    Bronchiolitis obliterans syndrome associated with an immune checkpoint inhibitor in a patient with non-small cell lung cancer.

    Takeda K, Miwa H, Kono M, et al.

    Respiratory medicine case reports 2023; (42()):101824 doi:10.1016/j.rmcr.2023.101824.

    PMID: 36910019

This page is for informational purposes only and does not constitute medical advice; it cannot determine the cause of your bronchiolitis obliterans. Do not stop a prescribed medicine or change treatment without speaking with your clinician.